Last Tuesday, the Center for Medicare and Medicaid Services (CMS) announced the first 10 medicines that will be subject to price negotiations with Medicare starting in 2026 per authorization in … Continue reading The Medicare Drug Pricing Program will Attract Uncomfortable Attention to the Rest of the Industry